Should I Buy SVA Stock in 2026?
Data-driven analysis and honest assessment for Sinovac Biotech Ltd
Current Price: $0.00P/E: 6.7
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Very low P/E of 6.7 suggests undervaluation
Growth data limited
Profitability data limited
Financial health data limited
Cash flow data limited
No recent insider activity
Key Investment Metrics
Current Price
$0.00
P/E Ratio
6.66
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$0.6B
Dividend Yield
850.08%
How SVA Compares to Competitors
Understanding how SVA stacks up against peers helps inform your investment decision.
How SVA Compares to Peers
Upcoming Events for SVA
+5 Reasons TO Buy SVA
1. Attractively valued at 6.7x earnings
strongA P/E ratio of 6.7 is below the market average of ~20x, suggesting the stock may be undervalued.
2. Attractive dividend yield of 850.1%
strongDividend yield above 3% provides meaningful income and signals management confidence.
-5 Reasons NOT to Buy SVA
1. Small-cap volatility risk
medium riskMarket cap under $2B means higher volatility and lower liquidity.
2. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy SVA?
Investment Profile
Risk Level
Very High
Recommended Holding Period
1-3 years or long-term income
Best For:
- ✓
Income Investors
850.1% yield provides regular income
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in SVA, compare these Healthcare peers:
Pro tip: Compare SVA directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for SVA
Frequently Asked Questions
What is SVA stock price today?
Visit our real-time dashboard for the current SVA stock price and live market data.
Is SVA stock going up or down today?
SVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy SVA stock now?
The decision to buy SVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is SVA a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for SVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is SVA stock overvalued or undervalued?
SVA currently trades at a P/E ratio of 6.66, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if SVA is fairly priced.
What is SVA's P/E ratio?
SVA has a price-to-earnings (P/E) ratio of 6.66, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is SVA's market cap?
SVA (Sinovac Biotech Ltd) has a market capitalization of $0.64 billion, making it a small-cap stock.
What is SVA's price to book ratio?
Price-to-book ratio for SVA is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Sinovac Biotech Ltd
Full Stock Analysis
Complete SVA overview with charts and data
Is SVA Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how SVA stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Sinovac Biotech Ltd
Complete SVA Analysis
Compare SVA With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.